During the past decade, Northwestern Center for Clinical Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern Center for Clinical Research" #1 sponsor was "Novartis Pharmaceuticals" with 5 trials, followed by "Mesoblast, Inc." with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Center for Clinical Research" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Triphase" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Center for Clinical Research" are "Osteoporosis" (4 trials), "Graft Versus Host Disease" (2 trials), "Advanced Solid Tumor" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "Northwestern Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Northwestern Center for Clinical Research" are "Drug" (16 trials), "Device" (2 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Zoledronic Acid" (3 trials), "Prochymal®" (2 trials), "Alfuzosin (SL770499)" (1 trials) and "Bone morphogenetic protein 7" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Center for Clinical Research" are 13 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Northwestern Center for Clinical Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Northwestern Center for Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Center for Clinical Research, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".